– USA, TN – iO Urology announced the addition of Steve Blum to its Board of Directors, bringing a wealth of experience and an impressive track record of success in the urological medical device industry.
About Steve Blum
Steve Blum joins iO Urology with a distinguished background, including recent roles as Global President at Coloplast and American Medical Systems. Over his six-year tenure at Coloplast, Blum led the company’s Men’s Health, Endosurgery, and Women’s Health Interventional Urology divisions. Under his leadership, Coloplast achieved remarkable global growth and operational excellence.
Before his role at Coloplast, Steve Blum served as Global President and General Manager of the FPH Division at American Medical Systems, overseeing operations in 75 countries. His leadership was pivotal in positioning American Medical Systems as a leader in the development and marketing of medical devices focused on restoring pelvic health for both men and women.
About iO Urology
iO Urology is a pioneering leader in the urological care field, dedicated to advancing patient outcomes by offering a convenient, accessible solution for managing urological conditions in the home. Using embedded cellular connectivity, the CarePath device provides reliable, accurate data that improves the diagnosis and management of lower urinary tract symptoms. Our mission is to develop and deliver cutting-edge solutions that address the complexities of urological conditions, enhancing both patient quality of life and clinical effectiveness. iO Urology strives to set new standards in the industry by empowering both patients and healthcare professionals with the knowledge they need to make informed decisions.
For more information: https://i-ourology.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.